$GILD Recent News Facebook, Biogen, Cal-Maine are stocks

New Post Public Reply Private Reply Replies (0) Message Board

Apr 2, 2014 at 6:23 PM

$GILD Recent News

Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Bombora watch, the 'momo' chart of pain and 5 reasons to buy Citigroup 8:33 a.m. March 28, 2014 - blogs.marketwatch.com
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
Newscast: Stocks close lower after late fade 4:26 p.m. March 21, 2014 - MarketWatch
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Picking stocks to weather any market 1:15 p.m. March 21, 2014 - Mark Hulbert
The Nasdaq has a message to deliver 1:56 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang

The Medicines Co. Falls on Angiomax Woes - Analyst Blog 53 min ago - Zacks.com
Biotech Giants Now Priced Like Old World Drug Stocks 2:43 p.m. Today - 247WallSt.com
SCYNEXIS Should Treat Its Own Fungus Pre-IPO 2:37 p.m. Today - Seeking Alpha
Celgene Extends Ties with Forma Therapeutics - Analyst Blog 11:40 a.m. Today - Zacks.com
Jim Cramer's Stop Trading: GOOG GILD 11:10 a.m. Today - TheStreet.com
Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog 10:43 a.m. Today - Zacks.com
Meet Nasdaq Composite 2.0 10:15 a.m. Today - FOXBusiness
Gilead's HepC Drug Sales May Be More Resilient Than Feared 10:10 a.m. Today - benzinga.com
Gilead (GILD) Leading In Pre-Market Activity 8:16 a.m. Today - TheStreet.com
Large Cap Biotechs Trading With Only Big Pharma P/E Ratios 7:30 a.m. Today - 247WallSt.com
Cramer's Mad Money - Bursting The Bears' Bubble (4/1/14) 5:25 a.m. Today - Seeking Alpha
'Fast Money' Recap: A Market In Higher Gear 5:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: The Market's Short-Term Memory 8:13 p.m. April 1, 2014 - TheStreet.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. April 1, 2014 - TheStreet.com
Update on Pfizer's OTC Nexium 24HR - Analyst Blog 4:30 p.m. April 1, 2014 - Zacks.com
Oxygen Biotherapeutics Up on FDA News - Analyst Blog 3:13 p.m. April 1, 2014 - Zacks.com
3 Stocks Driving The Drugs Industry Higher 1:03 p.m. April 1, 2014 - TheStreet.com
Cubist Rises on Favorable FDA Panel View - Analyst Blog 11:30 a.m. April 1, 2014 - Zacks.com
First Week Of GILD November 22nd Options Trading 10:51 a.m. April 1, 2014 - TheStreet.com
Stock Market News for April 01, 2014 - Market News 10:06 a.m. April 1, 2014 - Zacks.com

Gilead Announces Results From Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan 4:30 p.m. Today - BusinessWire - BZX
Critical Alerts For Ford, Castlight Health, Gilead Sciences, Take Two Interactive, and Qihoo 360 Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Comprehensive Technical Coverage on Active Equities -- Research on Sirius XM, Gilead Sciences, Microsoft, and Yahoo! 12:03 p.m. March 31, 2014 - PR Newswire - PRF
Gilead Announces Settlement Method for 1.00% Convertible Senior Notes Due 2014 8:30 a.m. March 28, 2014 - BusinessWire - BZX
Gilead's Marketing Application Validated by EMA; Accenture Misses Zack's Consensus Estimate 12:38 a.m. March 28, 2014 - ACCESSWIRE
European Medicines Agency Validates Gilead’s Marketing Application for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Chronic Hepatitis C Infection 4:10 p.m. March 27, 2014 - BusinessWire - BZX
Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 8:00 a.m. March 24, 2014 - PR Newswire - PRF
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case 7:01 a.m. March 24, 2014 - GlobeNewswire
Gilead Sciences Prices Hepatitis C Drug at $84,000; Versartis Commences Trading on the NASDAQ 12:30 a.m. March 24, 2014 - ACCESSWIRE
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...